Kleiner Perkins Caufield & Byers XIV, LLC
CIK 1505781 · last filed 2019-05-06
Kleiner Perkins Caufield & Byers XIV, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for BYND, was dated May 6, 2019. Current disclosed insider exposure totals $4.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.34M
2
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BYND | 10%+ Owner | 7,751,463 | $0.56 | $4.34M | $0 | 1 | 2019-05-06 |
| Foundation Medicine, Inc. (FMI) Delisted | 10%+ Owner | 37,020 | — | — | $0 | 2 | 2015-04-14 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-06 | BYND | Conv (C) | +23,254,389 | $0 | EDGAR |
| 2015-04-14 | Foundation Medicine, Inc. (FMI) Delisted | U | −7,044,582 | -$352.23M | EDGAR |
| 2013-10-02 | Foundation Medicine, Inc. (FMI) Delisted | Conv (C) | +10,568,451 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.